Morning Trend | CHINARES PHARMA's decline at low levels slows down, can news catalysts reverse the situation?

China Resources Pharmaceutical (3320.HK) has recently seen its stock price continue to decline, but the pace of the drop has gradually slowed, with short-term declines tending to converge. The daily MACD remains in a bearish crossover, but the green bars show signs of narrowing, indicating a marginal weakening of bearish strength. Currently, the K-line trend is stabilizing in a low range, with capital outflows slowing down, and some bottom-fishing funds are beginning to tentatively position themselves. In terms of the company's fundamentals, the pharmaceutical industry is under overall pressure, with rapid sector rotation. However, some policy support and progress in innovative businesses provide certain imaginative space for the future market. If there are favorable industry developments or catalysts such as the approval of innovative drugs or new products at the company level, the stock price may experience a rapid recovery. From a technical perspective, a phase bottom is currently being constructed. If it can effectively break through the pressure of the 5-day and 10-day moving averages, along with increased trading volume, it may be seen as a reversal signal. Overall, it is necessary to observe whether bullish momentum continues to strengthen. Operational advice suggests gradually accumulating at low levels, paying attention to changes in trading volume and news catalysts. If it continues to operate weakly in the future, a quick in-and-out strategy should be adopted, maintaining a flexible trading strategy to manage risk effectively